Sep 9, 2026 04:05PM
Sep 9, 2026 04:05PM
Aug 12, 2026 08:00AM
May 14, 2026 08:01AM
May 14, 2026 08:00AM
May 13, 2026 08:00AM
Mar 13, 2026 08:24AM Leerink Partners Reiterates Market Perform Rating on Century Therapeutics (IPSC)
Mar 12, 2026 08:00AM
Nov 13, 2025 07:02AM
Nov 13, 2025 07:00AM
Apr 28, 2025 04:30PM
Apr 15, 2025 04:01PM
Mar 19, 2025 04:01PM
Jan 21, 2025 07:03AM Century Therapeutics (IPSC) Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned
Jan 21, 2025 07:00AM
Nov 5, 2024 09:05AM
Nov 5, 2024 09:00AM
Sep 26, 2024 07:00AM
Sep 26, 2024 07:00AM
Aug 8, 2024 07:30AM
Jun 3, 2024 07:00AM Century Therapeutics (IPSC) Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
Jun 3, 2024 07:00AM
May 10, 2024 07:00AM
May 9, 2024 07:30AM
Apr 11, 2024 07:02AM
Apr 11, 2024 07:00AM
Apr 8, 2024 04:05PM
Mar 19, 2024 07:00AM Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Mar 14, 2024 07:30AM
Mar 5, 2024 06:03PM
Feb 1, 2024 07:00AM
Dec 9, 2023 12:00PM
Dec 6, 2023 07:31AM
Dec 6, 2023 07:30AM
Dec 6, 2023 07:30AM Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
Dec 6, 2023 07:30AM
Nov 21, 2023 07:00AM
Nov 9, 2023 07:02AM
Nov 9, 2023 07:01AM
Nov 9, 2023 07:01AM
Nov 9, 2023 07:00AM
Nov 9, 2023 07:00AM Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
Nov 2, 2023 09:00AM
Sep 26, 2023 07:00AM
Aug 9, 2023 07:30AM
May 11, 2023 07:30AM
Apr 17, 2023 07:00AM
Apr 17, 2023 07:00AM
Apr 12, 2023 08:34AM Century Therapeutics (IPSC) Announces Leadership Changes
Apr 12, 2023 08:30AM

330,654 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All